Neuroscientific Biopharmaceuticals Ltd (ASX:NSB)

Matthew Liddelow
MD & CEO
Market Cap (AUD): 43.76M
Sector: Health Care
Last Trade (AUD): 0.305 +0 (+0%)
Tab Bar

1. About

Neuroscientific Biopharmaceuticals (ASX:NSB) is an Australian company developing novel peptide-based pharmaceutical products that target a number of neurological disorders and diseases of the eye that have high unmet medical need.

The company's vision is to transform how the pharmaceutical industry approaches the understanding and treatment of neurodegenerative disease such as Alzheimer’s Disease.

The company believes that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk